Inclusion Criteria:

- Surgically staged and histologically confirmed diagnosis of MMMT

- 18 years of age or older

- ECOG Performance Score of 0-2

- Adequate bone marrow function

- Adequate renal function

- Adequate hepatic function

- Patients must be recovered from both the acute and late effects of any prior surgery

Exclusion Criteria:

- Patients with an active infection

- Patients with CNS metastases

- History of prior malignancy within the past 5 years except curatively treated basal
cell carcinoma of the skin, or cervical intraepithelial neoplasia

- Known hypersensitivity to any of the components of oxaliplatin or gemcitabine

- Prior radiation to the pelvis

- Patients who are receiving concurrent investigational therapy or who have received
investigational therapy within 30 days

- Peripheral neuropathy greater or equal to Grade 2

- Stage IV visceral disease (lung and liver metastases at presentation)

- Any other medical condition, including mental illness or substance abuse, deemed by
the investigator to be likely to interfere with a patient's ability to sign informed
consent

- Known HIV or Hepatitis B or C (active, previously treated or both)

- Pregnant or breast feeding